Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | CTSG | P08311 | 1/20 | 0.41 |
| ▸ | CTRC | Q99895 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12099122 | 0.83 | F2 (0.44) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL1364091 | 0.80 | F2 (0.41) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL7075011 | 0.78 | L3MBTL1 (0.47) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL9634672 | 0.75 | L3MBTL1 (0.38) | L3MBTL1 | |
| SCHEMBL10766774 | 0.73 | F2 (0.38) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL13853157 | 0.72 | F2 (0.46) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL13853142 | 0.72 | L3MBTL1 (0.48) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL1362157 | 0.71 | F2 (0.44) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL5075056 | 0.71 | F2 (0.44) | L3MBTL1USP2SMN1; SMN2F2ELANE | |
| SCHEMBL28212742 | 0.71 | F2 (0.39) | L3MBTL1USP2SMN1; SMN2F2ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025380-A1 | PERSONAL CARE DISSOLVABLE SHEET, COMPOSITIONS, METHODS OF MAKING AND USING THE SAME | IPX, LLC (US) | 2025-01-23 | — | — | US | disclosed |
| US-20030228272-A1 | Novel antidandruff conditioning shampoo | RNA CORPORATION | 2003-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030228272-A1 | Novel antidandruff conditioning shampoo | SMURF1, ITCH, SMURF2 | L3MBTL1 4627/4885USP2 2983/4885SMN1; SMN2 3844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.